Found: 3
Select item for more details and to access through your institution.
A safety and pharmacodynamics study of temelimab, an antipathogenic human endogenous retrovirus type W envelope monoclonal antibody, in patients with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 7, p. 1111, doi. 10.1111/dom.14010
- By:
- Publication type:
- Article
Efficacy and safety of temelimab in multiple sclerosis: Results of a randomized phase 2b and extension study.
- Published in:
- Multiple Sclerosis Journal, 2022, v. 28, n. 3, p. 429, doi. 10.1177/13524585211024997
- By:
- Publication type:
- Article
Defining the next generation of severe malaria treatment: a target product profile.
- Published in:
- Malaria Journal, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12936-024-04986-z
- By:
- Publication type:
- Article